Breakthrough low-energy cardioversion therapy for atrial fibrillation
About Us
Company
Executive Management
Scientific Advisory Board
Board of Directors
Research and Development
Licenses and Intellectual Property
Market
News
Press Releases
Presentations
Publications
Contacts
News
Recent News
CardiaLen Receives Significant Financing from Broadview Ventures to Complete Studies in Atrial Fibrillation
CardiaLen Awarded Phase I SBIR Grant
CardiaLen receives second round financing